You can buy or sell NVUS and other stocks, options, ETFs, and crypto commission-free!
Novus Therapeutics Inc. engages in the research and development of pharmaceutical products for patients with disorders of the ear, nose, and throat. The company operates under the surfactant and foam platforms. Read More The surfactant platform develops a treatment option for otitis media under OP0201 pipeline. The foam platform is used as a delivery vehicle for drugs to be administered into the ear canals, as well as the nasal and sinus cavities. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.
52 Week High
52 Week Low
— per share
-$0.47 per share